170 related articles for article (PubMed ID: 18390808)
1. p38 mitogen-activated protein kinase-dependent tumor necrosis factor-alpha-converting enzyme is important for liver injury in hepatotoxic interaction between lipopolysaccharide and ranitidine.
Deng X; Lu J; Lehman-McKeeman LD; Malle E; Crandall DL; Ganey PE; Roth RA
J Pharmacol Exp Ther; 2008 Jul; 326(1):144-52. PubMed ID: 18390808
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil interaction with the hemostatic system contributes to liver injury in rats cotreated with lipopolysaccharide and ranitidine.
Deng X; Luyendyk JP; Zou W; Lu J; Malle E; Ganey PE; Roth RA
J Pharmacol Exp Ther; 2007 Aug; 322(2):852-61. PubMed ID: 17505017
[TBL] [Abstract][Full Text] [Related]
3. Gene expression analysis points to hemostasis in livers of rats cotreated with lipopolysaccharide and ranitidine.
Luyendyk JP; Mattes WB; Burgoon LD; Zacharewski TR; Maddox JF; Cosma GN; Ganey PE; Roth RA
Toxicol Sci; 2004 Jul; 80(1):203-13. PubMed ID: 15084757
[TBL] [Abstract][Full Text] [Related]
4. Coagulation-mediated hypoxia and neutrophil-dependent hepatic injury in rats given lipopolysaccharide and ranitidine.
Luyendyk JP; Shaw PJ; Green CD; Maddox JF; Ganey PE; Roth RA
J Pharmacol Exp Ther; 2005 Sep; 314(3):1023-31. PubMed ID: 15933155
[TBL] [Abstract][Full Text] [Related]
5. Role of hepatic fibrin in idiosyncrasy-like liver injury from lipopolysaccharide-ranitidine coexposure in rats.
Luyendyk JP; Maddox JF; Green CD; Ganey PE; Roth RA
Hepatology; 2004 Dec; 40(6):1342-51. PubMed ID: 15565632
[TBL] [Abstract][Full Text] [Related]
6. The role of tumor necrosis factor alpha in lipopolysaccharide/ranitidine-induced inflammatory liver injury.
Tukov FF; Luyendyk JP; Ganey PE; Roth RA
Toxicol Sci; 2007 Nov; 100(1):267-80. PubMed ID: 17698507
[TBL] [Abstract][Full Text] [Related]
7. Unique gene expression and hepatocellular injury in the lipopolysaccharide-ranitidine drug idiosyncrasy rat model: comparison with famotidine.
Luyendyk JP; Lehman-McKeeman LD; Nelson DM; Bhaskaran VM; Reilly TP; Car BD; Cantor GH; Maddox JF; Ganey PE; Roth RA
Toxicol Sci; 2006 Apr; 90(2):569-85. PubMed ID: 16415329
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil-cytokine interactions in a rat model of sulindac-induced idiosyncratic liver injury.
Zou W; Roth RA; Younis HS; Malle E; Ganey PE
Toxicology; 2011 Dec; 290(2-3):278-85. PubMed ID: 22019926
[TBL] [Abstract][Full Text] [Related]
9. Reactive oxygen species and p38 mitogen-activated protein kinase mediate tumor necrosis factor α-converting enzyme (TACE/ADAM-17) activation in primary human monocytes.
Scott AJ; O'Dea KP; O'Callaghan D; Williams L; Dokpesi JO; Tatton L; Handy JM; Hogg PJ; Takata M
J Biol Chem; 2011 Oct; 286(41):35466-35476. PubMed ID: 21865167
[TBL] [Abstract][Full Text] [Related]
10. Cytochrome P4502E1 sensitizes to tumor necrosis factor alpha-induced liver injury through activation of mitogen-activated protein kinases in mice.
Wu D; Cederbaum A
Hepatology; 2008 Mar; 47(3):1005-17. PubMed ID: 18095305
[TBL] [Abstract][Full Text] [Related]
11. Ranitidine treatment during a modest inflammatory response precipitates idiosyncrasy-like liver injury in rats.
Luyendyk JP; Maddox JF; Cosma GN; Ganey PE; Cockerell GL; Roth RA
J Pharmacol Exp Ther; 2003 Oct; 307(1):9-16. PubMed ID: 12893837
[TBL] [Abstract][Full Text] [Related]
12. Coagulation-dependent gene expression and liver injury in rats given lipopolysaccharide with ranitidine but not with famotidine.
Luyendyk JP; Lehman-McKeeman LD; Nelson DM; Bhaskaran VM; Reilly TP; Car BD; Cantor GH; Deng X; Maddox JF; Ganey PE; Roth RA
J Pharmacol Exp Ther; 2006 May; 317(2):635-43. PubMed ID: 16401727
[TBL] [Abstract][Full Text] [Related]
13. Metabonomic evaluation of idiosyncrasy-like liver injury in rats cotreated with ranitidine and lipopolysaccharide.
Maddox JF; Luyendyk JP; Cosma GN; Breau AP; Bible RH; Harrigan GG; Goodacre R; Ganey PE; Cantor GH; Cockerell GL; Roth RA
Toxicol Appl Pharmacol; 2006 Apr; 212(1):35-44. PubMed ID: 16051291
[TBL] [Abstract][Full Text] [Related]
14. Hepatotoxic interaction of sulindac with lipopolysaccharide: role of the hemostatic system.
Zou W; Devi SS; Sparkenbaugh E; Younis HS; Roth RA; Ganey PE
Toxicol Sci; 2009 Mar; 108(1):184-93. PubMed ID: 19074762
[TBL] [Abstract][Full Text] [Related]
15. Liver X receptor agonist GW3965 dose-dependently regulates lps-mediated liver injury and modulates posttranscriptional TNF-alpha production and p38 mitogen-activated protein kinase activation in liver macrophages.
Wang YY; Dahle MK; Steffensen KR; Reinholt FP; Collins JL; Thiemermann C; Aasen AO; Gustafsson JA; Wang JE
Shock; 2009 Nov; 32(5):548-53. PubMed ID: 19295476
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional and posttranscriptional roles for p38 mitogen-activated protein kinase in upregulation of TNF-alpha expression by deoxynivalenol (vomitoxin).
Chung YJ; Zhou HR; Pestka JJ
Toxicol Appl Pharmacol; 2003 Dec; 193(2):188-201. PubMed ID: 14644621
[TBL] [Abstract][Full Text] [Related]
17. Effects of a dual inhibitor of tumor necrosis factor-alpha and interleukin-1 on lipopolysaccharide-induced lung injury in rats: involvement of the p38 mitogen-activated protein kinase pathway.
Yoshinari D; Takeyoshi I; Koibuchi Y; Matsumoto K; Kawashima Y; Koyama T; Ohwada S; Morishita Y
Crit Care Med; 2001 Mar; 29(3):628-34. PubMed ID: 11373433
[TBL] [Abstract][Full Text] [Related]
18. p38 mitogen-activated protein kinase inhibition attenuates burn-induced liver injury in rats.
Chen XL; Xia ZF; Yu YX; Wei D; Wang CR; Ben DF
Burns; 2005 May; 31(3):320-30. PubMed ID: 15774288
[TBL] [Abstract][Full Text] [Related]
19. Intracellular signaling in rat cultured vascular smooth muscle cells: roles of nuclear factor-kappaB and p38 mitogen-activated protein kinase on tumor necrosis factor-alpha production.
Yamakawa T; Eguchi S; Matsumoto T; Yamakawa Y; Numaguchi K; Miyata I; Reynolds CM; Motley ED; Inagami T
Endocrinology; 1999 Aug; 140(8):3562-72. PubMed ID: 10433212
[TBL] [Abstract][Full Text] [Related]
20. SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung.
Underwood DC; Osborn RR; Bochnowicz S; Webb EF; Rieman DJ; Lee JC; Romanic AM; Adams JL; Hay DW; Griswold DE
Am J Physiol Lung Cell Mol Physiol; 2000 Nov; 279(5):L895-902. PubMed ID: 11053025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
